<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37145011</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>18</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>PADI4 and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus and juvenile idiopathic arthritis, a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e33700</StartPage><MedlinePgn>e33700</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33700</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000033700</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study evaluated the association between peptidyl arginine deiminase type IV (PADI4) and interleukin 33 (IL-33) with systemic lupus erythematosus (SLE) and juvenile idiopathic arthritis (JIA).</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We searched the PubMed, Web of Science, Embase and Cochrane Library databases to retrieve articles published up to January 20, 2023. Stata/SE 17.0 (College Station, TX) software was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs). The cohort study, case-control study focusing on the PADI4, IL-33 polymorphism, and SLE, JIA were retrieved. The data included basic information of each study and the genotypes and allele frequencies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Studies in PADI4 rs2240340 = 2 and 3 IL-33(rs1891385 = 3, rs10975498 = 2, rs1929992 = 4) were found in 6 articles. Overall, only the IL-33 rs1891385 show significant association between SLE in all 5 models. The results were OR (95% CI) = 1.528 (1.312, 1.778), P = .000 in Allele model (C vs A), OR (95% CI) =1.473 (1.092, 1.988), P = .000 in Dominant model (CC + CA vs AA), 2.302 (1.583, 3.349), P = .000 in Recessive model (CC vs CA + AA), 2.711 (1.845, 3.983), P = .000 in Homozygote model (CC vs AA), 5.568 (3.943, 7.863), P = .000 in Heterozygote model (CA vs AA). PADI4 rs2240340, IL-33 rs10975498, IL-33 rs1929992 were not found to be association with the risk of SLE and JIA. In gene model, statistically significant association was found between IL-33 rs1891385 and SLE in sensitivity analysis. Egger's publication bias plot showed there was no publication bias (P = .165). Only in recessive model the heterogeneity test was significant (I2 = 57.9%, P &#x2264; .093) of IL-33 rs1891385.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The current study suggests that in all 5 model, IL-33 rs1891385 polymorphism may be associated with genetic susceptibility to SLE. There was unclear association found between PADI4 rs2240340, IL-33 rs10975498, and IL-33 rs1929992 polymorphisms and SLE and JIA. Due to the limitations of included studies and the risk of heterogeneity, additional research is required to confirm our findings.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42023391268.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9439-3567</Identifier><AffiliationInfo><Affiliation>Yuhuan People's Hospital, Taizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Pingping</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yangjun</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuechao</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.5.3.15</RegistryNumber><NameOfSubstance UI="D000080002">Protein-Arginine Deiminase Type 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067596">Interleukin-33</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="Y">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080002" MajorTopicYN="N">Protein-Arginine Deiminase Type 4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067596" MajorTopicYN="N">Interleukin-33</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37145011</ArticleId><ArticleId IdType="pmc">PMC10158862</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000033700</ArticleId><ArticleId IdType="pii">00005792-202305050-00028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kotait MA, Abd Elnabi HH, Gabr TA. Juvenile systemic lupus erythematosus (jSLE): auditory pathway affection in relation to disease activity. Int J Pediatr Otorhinolaryngol. 2017;93:150&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28109488</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao J, Qiu F, Li T, et al. . Circulating angiogenic T cells and their subpopulations in patients with systemic lupus erythematosus. Mediators Inflamm. 2016;2016:2842143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4811166</ArticleId><ArticleId IdType="pubmed">27065298</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, An Y, Jiang D, et al. . TNF-&#x3b1; regulating interleukin-33 induces acute pancreatic inflammation in rats. Ann Clin Lab Sci. 2016;46:54&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26927343</ArticleId></ArticleIdList></Reference><Reference><Citation>Gl&#xfc;ck J, Rymarczyk B, Kasprzak M, et al. . Increased levels of interleukin-33 and thymic stromal lymphopoietin in exhaled breath condensate in chronic bronchial asthma. Int Arch Allergy Immunol. 2016;169:51&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26953567</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, M&#xe9;nard HA. Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis? Curr Opin Rheumatol. 2002;14:250&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11981322</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Allah SH, el-Shal AS, Shalaby SM, et al. . PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients. Joint Bone Spine. 2012;79:124&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21981985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandjbakhch F, Fajardy I, Ferr&#xe9; B, et al. . A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population. J Rheumatol. 2009;36:881&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19332633</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CC, Isomoto H, Narumi Y, et al. . Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population. Clin Immunol. 2008;126:165&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">17980669</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark MF, Baudouin SV. A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med. 2006;32:1706&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">16957907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali MA, Abdelaziz A, Ali M, et al. . PADI4 (rs2240340), PDCD1 (rs10204525), and CTLA4 (231775) gene polymorphisms and polyarticular juvenile idiopathic arthritis. Br J Biomed Sci. 2020;77:123&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32163016</ArticleId></ArticleIdList></Reference><Reference><Citation>Massarenti L, Enevold C, Damgaard D, et al. . Peptidylarginine deiminase-4 gene polymorphisms are associated with systemic lupus erythematosus and lupus nephritis. Scand J Rheumatol. 2019;48:133&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">30269634</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu WD, Liu Y, Ye DQ. Association between IL-33 gene polymorphisms (rs1929992, rs7044343) and systemic lupus erythematosus in a Chinese Han population. Immunol Invest. 2016;45:575&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">27603301</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Xiang Y, Peng YF, et al. . The association of novel IL-33 polymorphisms with sIL-33 and risk of systemic lupus erythematosus. Mol Immunol. 2016;77:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27449905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Xie L, Qin H, et al. . Interaction between IL-33 gene polymorphisms and current smoking with susceptibility to systemic lupus erythematosus. J Immunol Res. 2019;2019:1547578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6432724</ArticleId><ArticleId IdType="pubmed">30984790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hisa K, Yanagimachi MD, Naruto T, et al. . PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis. PLoS One. 2017;12:e0171961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5300194</ArticleId><ArticleId IdType="pubmed">28182665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Liang Y, Xi W, et al. . Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med. 2011;11:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">20963466</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Mu R, Guo J, et al. . Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis. Arthritis Res Ther. 2014;16:R105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4075243</ArticleId><ArticleId IdType="pubmed">24779919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu X. PADI4 and IL-33 gene polymorphisms associated with differential susceptibility to juvenile-onset systemic lupus erythematosus and juvenile idiopathic arthritis in Chinese children. Medicine (Baltimore). 2022;101:e31598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9771228</ArticleId><ArticleId IdType="pubmed">36550815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>